尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Delfini Lisa. Insider active across 1 company, notably Trevi Therapeutics, Inc.. Cumulatively, 11 disclosures have been recorded. Activity tracked since 13 February 2023. The latest transaction was disclosed on 7 January 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Delfini Lisa is a declarant linked to Trevi Therapeutics, Inc., where the listed role is Chief Financial Officer. They have 11 filings in total, and in the recent sampled filings covered from 2023-02-15 to 2025-01-10, the most common transaction nature is Levée d'options, with buy and sell amounts of EUR 0.